Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Ixazomib’s phase 3 study
.
Show all posts
Showing posts with label
Ixazomib’s phase 3 study
.
Show all posts
Thursday, December 3, 2015
Ixazomib’s phase 3 study in relapsed/refractory multiple myeloma presented
›
Takeda Pharmaceutical Company Limited today announced that it will present Phase 3 data from the TOURMALINE-MM1 ixazomib clinical tr...
›
Home
View web version
